Historical record - last NADAC publication: 11/20/2019

Product Information

RAMIPRIL 2.5 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0719 per EA under NDC 00054010720. Its NADAC has been published 314 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RAMIPRIL 2.5 MG CAPSULE

Ramipril
$0.0719per EA
High Outlier

Strength

2.5 mg/1

NDC

00054010720

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

11/20/2019

Active Ingredients

RAMIPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA077900

On Market Since

6/18/2008

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for RAMIPRIL 2.5 MG CAPSULE has been published 314 times since Nov 28, 2013, and over the history we have for it it has declined 13.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0719 per EA
All-time high$0.0900 (Apr 15, 2015)
All-time low$0.0603 (Apr 17, 2019)
Median price$0.0766
Average price$0.0764
Largest weekly change+29.9% (May 22, 2019)
Weeks tracked314
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-13.9%

Generic Alternatives

The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RAMIPRIL 2.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 2.5 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0719 per EA (NDC 00054010720), effective Nov 27, 2019.

How has the price of RAMIPRIL 2.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RAMIPRIL 2.5 MG CAPSULE has declined 13.9%. It has been tracked across 314 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RAMIPRIL 2.5 MG CAPSULE?

Since Nov 28, 2013, the NADAC for RAMIPRIL 2.5 MG CAPSULE has ranged from a low of $0.0603 (Apr 17, 2019) to a high of $0.0900 (Apr 15, 2015), with a median of $0.0766 per EA.

Are there cheaper alternatives to RAMIPRIL 2.5 MG CAPSULE?

Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RAMIPRIL 2.5 MG CAPSULE, is $0.0474 per EA — about 34% below RAMIPRIL 2.5 MG CAPSULE.

Who manufactures RAMIPRIL 2.5 MG CAPSULE?

RAMIPRIL 2.5 MG CAPSULE (NDC 00054010720) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.